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Recent interest focused on the dynamics of HIV-1 replication in primary monocytes/macrophages and T-lymphocytes of
the immune system, as well as the standardization of virological and immunological in vitro assays with primary isolates,
provided the impetus for these studies. These types of studies have never been performed as they would occur in vivo,
i.e., where the envelope of the virus and cell membranes of the two cell types of the same host origin. Therefore, the
biological and physicochemical properties of an uncloned, primary dual-tropic isolate HIV-1ADA during the initial lag, log,
and stationary phases of viral replication were studied in an autologous donor cell assay in peripheral blood mononuclear
cells (PBMC) and blood monocyte-derived macrophages (MDM). Similar total numbers (109 virus particles/ml) were produced
by both cell types during the stationary period. On a per cell per day basis, during peak stationary periods, 0.92 1 103
virions/day for MDMs and 5.31 1 103 virions/day for PBMCs were produced. Interestingly, virus replicating from MDMs
during the log-growth phase demonstrated the greatest infectious fraction which was 3 logs greater than virus replicating
in PBMCs. Despite constant virus particle production in MDMs, the infectious fraction was found to fall 3 to 4 logs over a
10-day period. Due to an infectious fraction less than 1 (0.053 infectious unit/cell/24 hr), virus spread in PBMCs during the
rapid log phase could only have occurred by cell-to-cell contact, whereas in MDMs with an infectious fraction of about one
infectious particle (1/cell/24 hr), cell-free transmission could account for the observed results. Most of the MDMs (90%)
became productively infected, whereas only 5–10% of the total PBMCs were found replicating virus. The period of peak
stationary virus production (i.e., stationary phase) was at minimum 4 to 5 times longer in MDMs than PBMCs. Whereas the
majority of p24, RT, and gp120 found to be associated with MDM-derived virions, no increased dissociation of these
components was observed in PBMC-derived virions. The virion-associated gp120 was 3 to 4 times more stable on both
PBMC- and MDM-derived virus (96 hr) and present at 10–25 times the concentration per virion than that observed for a
T-cell-line-adapted laboratory strain of HIV-1 replicating in T-cell lines. These in vitro results suggest that important differ-
ences exist between MDMs and PBMCs with regard to the viral dynamics of infection and replication which should provide
for a qualitative and quantitative basis to estimate virus replication on a per-cell basis for other known cellular targets of
HIV-1. Studying the multiple biophysicochemical characteristics and viral replication dynamics as described herein provides
an autologous in vitro model of additional quantifiable parameters for analysis and understanding of virus/host factor(s)
and/or antivirals which influence them. q 1996 Academic Press, Inc.
INTRODUCTION turnover of both CD4-positive cells. Virus replication dy-
namics and CD4 cell turnover have become the focus of
Recent clinical virologic studies demonstrate that HIV- ongoing rapid surrogate markers and efficacy determi-
1 may prefer to replicate in various lineage-related mac- nants of antiretroviral therapy (Ho et al., 1995; Wei et al.,
rophages at local portals of entry and/or in T-lymphocytes 1995; Perelson et al., 1996). Recent discussions have
throughout the body early in infection and both of these centered around further characterizing and defining the
cell types may constitute a major source and subsequent dynamics and turnover of virus replication, infected cells,
lymphoid reservoir of virus burden (for a review see Levy, and host controlling interaction(s) (Chun et al., 1995; Ho
1993). CD4-bearing lymphocytes thus become infected et al., 1995; Wei et al., 1995; Levy et al., 1996; Perelson
during this initial lag-log phase of primary HIV-1 infection et al., 1996).
and are currently implicated in the maintenance of the In these in vivo settings, both the viral envelope and
plasma viral load and the subsequent high and rapid the host cell membranes for the de novo infected cell
types are from the same genetic origins. In addition, HIV-
1 isolates appear to change following transmission and/
1 The U.S. Government’s right to retain a nonexclusive royalty-free or exhibit a spectrum of differential characteristics during
license in and to the copyright covering this paper is hereby acknowl- disease progression in their biological and/or immuno-
edged.
logical properties such as replication capacity, cyto-2 To whom correspondence and reprint requests should be ad-
pathic effect, ability to down-regulate CD4, tissue-spe-dressed at Laboratory of Biochemical Physiology, NCI-FCRDC, P.O.
Box B, Building 560, Room 12-15, Frederick, MD 21702-1201. cific host range/tropism, and susceptibility to sCD4 and
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TABLE 1neutralizing antibodies and/or cytotoxic T-cells as they
are transmitted between macrophages, lymphocytes Characteristics of the HIV-1 Virus Stocks
and/or other cells in the body (Nara et al., 1992; Tsai et
ADAa MNaal., 1992; Weiss, 1993; Levy, 1993 for reviews). These
virological properties are greatly influenced in addition,
Titer 107 TCID50 /ml 2 1 105 SFU/mlby an array of intra- and extracellular biochemical and
p24 (ng/ml)biophysical characteristics such as the differences in
Prespin 850.0 2400rates of replication versus spontaneous decay rate usu-
Postspin 42.2 176ally associated with the shedding of virus-associated
Pelletb 807.8 2224
gp120 and/or the loss of reverse transcriptase activity,
Virion concentration in pelletthe concentration/density of the viral envelope gp120
(particles/ml) as(Layne et al., 1991, 1992), infectious to noninfectious ra-
determined by
tios, defective interfering particles, and complexity of the p24 16.2 1 109 44.5 1 109
viral quasi-species. These characteristics in turn may be EM 9.8 1 109 54.9 1109
influenced by the acquisition of various host/virus cell
a HIV-1ADA virus stock was made in rCSF-1 treated normal monocytesmembranes which include a growing list (i.e., HLA-DR,
as described under Materials and Methods and then concentrated 100-DP, DQ, B2-microglobulin, ICAM-1, LFA-1, CD43, CD44,
fold by directly pelleting from culture medium. A different batch with
CD46, CD55, CD59, CD63, and the transferrin (CD71) 10-fold concentration prepared in similar fashion was used for the
(Arthur et al., 1992; Cantin et al., 1996; Montefiori et al., replication study. HIV-1MN virus stock was made in H9. The stocks
were provided by Dr. H. F. Gendelman.1994; Orentas and Hildreth, 1993; Saifuddin et al., 1995)
b Calculated values: the difference between the prespin andand plasma proteins (Nara et al., 1991; Wu et al., 1995).
postspin.Given the paucity of biochemical and biophysical data
for primary isolates, and the need for more quantitative
and qualitative in vitro data regarding the dynamics of PBMCs of an HIV-1 seropositive male homosexual with
low CD4/ T cell counts (252 cells/mm3) and Kaposi’svirus replication, we have extended the previous studies
(Layne et al., 1991, 1992) to include a primary dual-tropic sarcoma for 4 years from which a limited passaged iso-
late was obtained (Gendelman et al., 1988). Titration ofisolate. Furthermore, as HIV-1 has been found to incorpo-
rate various host cell proteins and replicates in an autolo- the working HIV-1ADA/MDM stock was carried out in rCSF-
1-treated normal monocytes (cultured for 5 to 10 daysgous cell setting in vivo, we designed an in vitro autolo-
gous cell assay in an attempt to better mimick those in before use) and the final TCID50 was determined by end-
point serial dilutions and measured by quantitative p24vivo cellular conditions. Using growth cycle kinetic and
wash-out protocols in MDM and PHA-stimulated PBMCs ELISA at 2 weeks after infection. For this study HIV-
1ADA/MDM was also passaged in PBMCs and the virusfrom the same normal donor (autologous), several prop-
erties of a primary isolate of HIV-1 such as replication produced denoted as HIV-1ADA/PBMC . The HIV-1MN strain
was originally isolated from PBMCs of a pediatric patientrates, amounts of virus particles produced per cell, virion-
associated gp120 density and spontaneous shedding with AIDS-related complex by transmitting into JM T-cell
line (Wong-Staal et al., 1985) and subsequently main-rates, infectivity titrations, physical and biochemical parti-
cle enumeration, and infectious to noninfectious particle tained in the H9 transformed human T-cell line as HIV-
1MN/H9 . The virus stock was prepared in H9 cells usingratios were determined during the lag, log, and stationary
growth phases. The results from these preliminary in an acute infection protocol as described previously
(Layne et al., 1991). For titration of HIV-1MN/H9 virus stock,vitro studies demonstrated that unique differences in the
relationship between physicochemical and biological T-cell line CEM-SS was used as the indicator cells and
the titers were expressed in syncytial-forming unitsproperties occurred during viral replication of a primary
isolate of HIV-1 using an autologous primary cell system (SFU), which were quantitated on Day 5 after infection
(Nara et al., 1987). The two virus stocks were then com-as described here. This report is the first to report such
detailed in vitro viologic characterization utilizing an au- pletely characterized biochemically and biophysically for
total fractionated soluble and virion-associated p24 andtologous cell assay system.
total physical particles. To determine soluble and virion-
associated p24, the virus stocks were ultracentrifugedMATERIALS AND METHODS
and concentrations of p24 determined on both the pre-
Preparation of virus stocks
and postspin supernatants and viral pellets (summarized
in Table 1). The virion concentrations as determined byHIV-1 virus stocks were prepared using a uncloned,
dual-tropic, primary cell passaged isolate, HIV-1ADA , and electron microscopy (EM) and p24 for both stocks were
within an order of magnitude with each other. Thesea highly passaged uncloned CD4/ T-cell-tropic labora-
tory strain, HIV-1MN . Co-cultured with rCSF-1-treated nor- biochemical data served to characterize the input virus
inocula and provided a basis from which to measuremal monocytes, HIV-1ADA was originally isolated from
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subsequent samples during the lag, log, and stationary 1IIIB p24 ELISA kits (DuPont), previously quantitated and
standardized by amino acid analysis using recombinantphases in growth cycle presented later in the paper.
p24 (Layne et al., 1992). Estimation of virion concentration
Isolation and culture of macrophages and PHA- from p24 concentrations was made based on the calcu-
activated PBMCs lated and directly quantitated (direct particle counts and
quantitative p24 ELISA) value of 5 1 1008 ng of p24 perThe PHA-activated PBMCs and human monocytes/
macrophages were both isolated from the same donor’s virion determined previously (Layne et al., 1992).
The concentration of gp120 molecules per virion waspack (275 ml) through leukapheresis and by a pre-
viously published methodology (Tsai et al., 1991). The initially determined using a modified gp120 ELISA, origi-
nally established by Moore and co-workers (Moore andprocedure consisted of the standard Ficoll–Hypaque
gradient method followed by two sequential steps of ad- Jarrett, 1988; Moore et al., 1989). However, after finding
that the human serum in the media for monocyte/macro-herence to plastics. The primary adherence was done
with regular tissue culture flasks (polystyrene), followed phage cultures caused high background using this
assay, a modified procedure was developed in whichby a hydrophobic plastic (polypropylene) adherence. Pe-
ripheral blood from healthy donors was first fractionated HIV-1 positive human IgG was directly conjugated with
the enzyme. In brief, a gp120-specific carboxyl-terminalby the standard Ficoll–Hypaque gradient centrifugation
procedures. The fractions of mononuclear cells (PBMC) specific antibody coated on a microtiter plate was used
to capture gp120. The captured antigens were then de-were then pooled and washed, and erythrocytes were
removed with a lysing buffer (ACK, Quality Biological, tected by a pool of directly conjugated HIV-1 positive
human serum. Viral protein concentrations were deter-Inc., Gaithersburg, MD). PBMCs were then cultured in
polystyrene plastic flasks (Costar) for 1 hr with RPMI mined against standard curves using recombinant HIV-
1IIIB gp120 derived from CHO cells (Celltech). Estimatesmedium plus 2% fetal bovine serum (FBS). The unat-
tached cells were collected as the source of peripheral of the total mass of virion-associated gp120 on a per
virion basis were derived from dividing the pelleted virionblood mononuclear cells (PBMC). The PBMCs were acti-
vated and cultured in RPMI 1640 with 10% FBS and phyto- gp120 concentration (g/ml) by the virion concentration
(previously described above). The number of gp120 mole-hemagglutinin (PHA) (2 mg/ml) for 2 days, after which they
were then changed to medium containing interleukin 2 cules per virion were then obtained by dividing total
gp120 mass (g/virion) by 2 1 10019 g/molecule, the mass(IL-2) (Hoffmann-La Roche Inc. provided through Biologi-
cal Resources Branch, BRMP, DCT, NCI) at a concentra- of a gp120 molecule. The reverse transcriptase (RT) activ-
ity was measured by radioactive products produced bytion of 50 U/ml, and immediately infected.
The cells which adhered after the 1-hr incubation in the reaction of the sample with tritiated TTP and oligo(dT)
poly(A), as previously described (Layne et al., 1992).2% FBS described above were considered as crude prep-
arations of monocytes/macrophages and were further
Quantitative electronmicroscopycultured in RPMI with 5% FBS for additional 18–20 hr.
The cells were then harvested, washed, and subjected
Direct particle counts of virus were carried out as pre-
to the second step of adherence by culturing in polypro-
viously described (Layne et al., 1992). In brief, viral sam-
pylene in RPMI with 10% human AB type serum (Sigma)
ples were mixed with polystyrene spheres which were
for 5 days. Unattached cells were removed and the ad-
identical in density/size to virus particles resulting in 1
herent monolayer of cells were found to contain a highly 1 109 spheres/ml. Multiple cross-sectional analysis of
pure population of differentiated macrophages as deter-
the viral/polystyrene bead pellet was done to assess a
mined by electron microscopy, OKM1 staining, and non-
uniform distribution of beads and virus particles prior to
specific esterase activity (Sigma). The adherent macro-
counting. For each electron micrograph, total numbers
phages could then be scraped off from the plastic and
of viral particles and polystyrene spheres were counted
transferred to other tissue cultureware after incubation
and four random electron-micrographs were used to de-
for 30 min in cold PBS with 1 mM EDTA. The cells were
termine the final virion concentration for a sample. Previ-
then used either for infection immediately or cryo-pre-
ous studies suggested the sensitivity of quantitative par-
served as needed. A typical isolation from a pack of 275
ticle counts by EM require a minimum virus concentration
ml of healthy human blood obtained by leukapheresis
of approximately 1.0 1 106 particles/ml. Reproducibility
was found to contain approximately 6.41 109 total leuko-
of this procedure has previously been determined (Layne
cytes with approximately 11 108 cells being MDMs. This
et al., 1992; Lin et al., 1994) and repeated values fall
method routinely yields roughly 1.5% of the total PBMCs
within 0.25–0.50 logs at a 95% confidence interval.
obtained by this method (leukapheresis).
Autologous primary MDM/PBMC assayBiochemical characterization of HIV-1
Viral p24 antigen of the samples following treatment To better understand the in vivo relationship of viral
replication, growth kinetics, infectivity, tropism, etc.,with Triton X-100 was determined by a commercial HIV-
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where an autologous relationship exists between virus In addition, the contribution of infectious virus within
the intracellular MDM compartment was studied in aand host cells, we designed the primary autologous cell
assay. Both 2-day, PHA-activated PBMCs and 5-day dif- fashion similar to that for the replication rate study de-
scribed above, and the experiment was carried out inferentiated macrophages from the same donor were in-
fected with HIV-1ADA and HIV-1MN . In both cases, a total 48-well-plates at 3 1 105 cells/well. The cells were
scraped from the wells 14 days after the infection,of 18.6 1 106 cells were incubated with 1.1 ml of virus
inoculum (obtained by mixing 1 volume of virus stock washed extensively, placed in medium and disrupted by
three cycles of freeze/thaw with an ethanol/dry ice bath.with 1.5 volume of medium) which resulted in a m.o.i. of
0.006 for the HIV-1MN/H9 (as titered in CEM-SS cells) and The resulting cell lysates were then titrated for the infec-
tivity as described above.0.03 for the HIV-1ADA/MDM (titered in different donors mac-
rophages). Following a 90-min incubation, the cells were
washed three times and either resuspended in medium RESULTS
containing IL-2 for PBMCs or resuspended in RPMI1640
Replication kinetics, biochemical characteristics, and
medium containing 10% human AB sera for MDMs. A
infectivity of HIV-1ADA in MDMs and PBMCstotal of 15 1 106 cells in 7.5 ml of medium (for both cell
types) was then plated in T-25 flasks. Samples were then The dual-tropic primary isolate HIV-1ADA was pas-
saged through both MDMs and PBMCs to characterizetaken immediately (Day 0) for baseline determinations of
p24, RT, and gp120 concentrations. On Day 2 following various virological, biochemical, and biophysical prop-
erties. These include replication kinetics, the effect ofinfection fresh media were added to both the PBMCs
and MDM cultures to a final total volume of 11 ml. host cell passage, the quantitation of both soluble and
virion-associated major structural proteins (p24, RT, andTo monitor kinetics of viral replication in both PBMCs
and MDMs during the lag (early entry prior to detectable gp120), infectivity, virus particle quantitation as deter-
mined by both physical particle counts (EM) and thecell-free p24 detection), log-growth (exponential viral rep-
lication period), and stationary phases (peak sustained concentration of structural protein p24, and finally the
infective/noninfective ratios. The replication kinetics oflevels of viral replication), media were completely re-
moved from the cultures and the cells extensively HIV-1ADA on macrophages as measured by p24 antigen,
RT activity, and gp120 antigen in the culture media arewashed and replaced with 11 ml of fresh media con-
taining 20 – 30% conditioned RPMI 1640. This wash-out shown in Figs. 1A, 1B, and 1C, respectively. The lag
phase of virus replication in MDMs, (as defined to in-procedure was repeated every 3 or 4 days throughout
the lag, log, and stationary phases which lasted (de- clude eclipse time and time for the virus to spread) was
observed by the declining values of corresponding p24pending on the primary cell type) over a 10-day to 5-
week period. Samples for virus characterization were (Fig. 1A) and virion concentrations (Table 2) by 7 days,
after which, replication of the new virus was observedseparated by ultracentrifugation into viral pellets and pre-
spin and postspin supernates and assayed in all frac- to occur rapidly between Days 10 and 14 in log fashion
reaching peak stationary levels by Day 17 and continu-tions for p24, gp120, RT activity, and infectivity titrations
as well as particle counts by electron microscopy. The ing unabated to Day 29. Approximately 300 ng/ml of p24
(Fig. 1A) or 5.8 1 109 HIV-1 particles (Table 2) wereextensive characterization as described previously, and
cost associated with all these determinations, prevented made every 3 – 4 days during the log and stationary
phase (Day 14 to Day 24). The majority of viral proteinsus from repeating the experiment with more than one
HIV-1 isolate and one normal donor’s cells. Repeat exper- such as p24 antigens (99%), RT activity (100%), and
gp120 antigens (96%) were associated with the virusiments of the viral replication kinetics studies measuring
p24 were subsequently performed for HIV-1ADA/MDM on pellets following ultracentrifugation of the clarified cul-
ture media (Figs. 1B and 1C). In individual samplesdifferent donors’ cells as part of other studies (Tsai, in
preparation) and found to be similar to those observed taken from the log phase (Days 10 – 14 and 14 – 17),
gp120 was associated with the virus pellet, whereas atin this study.
To further characterize the relationship of infectivity of Day 20 a small amount of both soluble p24 (1%) and
gp120 (4%) was detected in the supernatant (Figs. 1AHIV-1ADA between MDMs and PBMC’s of the same donor,
with virus replicating in that donor’s cells, infectivity titra- and 1C and Table 2). The virus particle count calculated
from p24 concentration above was further confirmed bytions were done back on the same donor’s MDMs and
PBMCs (autologous cell assay). Serial kinetic samples quantitative EM. The cell-free HIV-1ADA concentrations
produced by MDMs ranged from 3.0 1 107 particles/mltaken from the HIV-1 infected MDMs and PBMCs above
were titered back on the same donor’s PBMCs and (Day 10) to 6 1 109 particles/ml (Day 20). These values
closely agreed (within twofold) with those determinedMDMs using 0.1 ml of the sample with a 10-fold dilution
series in duplicate and placed into 96-well microtiter on Days 20 and 24 by EM (Table 2). Similar kinetics of
RT activity (Fig. 1B) or gp120 antigens (Fig. 1C) coin-plates containing preplated uninfected primary cells and
incubated for 1 hr. cided with viral replication as measured by p24 antigen.
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this culture system was produced from both single and
multinucleated giant cells (data not shown). Also, no
intracellular infectious virus could be demonstrated
(data not shown).
For comparison, the uncloned HIV-1ADA/MDM was also
similarly characterized in autologous PHA-stimulated
PBMCs at the same m.o.i. of 0.03 (Figs. 2A, 2B, and
2C). Replicating virus, as measured by pelletable p24
antigens (Fig. 2A) appeared within 3 days after infec-
tion (log phase). Wash-out experiments done between
Day 3 and Day 6 (arrows) demonstrated an exponential
increase of both p24 and gp120 from 2 to 150 ng/
ml and 1 to 20 ng/ml, respectively (Figs. 2A and 2C).
Replication reached a peak level by Day 10 (200 ng/
ml p24), and declined over fivefold by Day 14. RT activ-
ity and gp120 antigen were undetectable until Day 6
(3 days later than p24), after which similar kinetics as
described previously were observed (Figs. 2B and 2C).
The p24 taken between Day 3 and Day 6 was mostly
associated with the virus pellet (80%). Greater amounts
of gp120 (90%), however, were found in the pellet
after ultracentrifugation. RT determined during the
same time (testing both the total and the virus pellet)
demonstrated that 50% of the activity was soluble. In
the following washout interval (Days 6 – 10), however,
approximately (within the error of the assay) 100% of
the RT activity and 100% of the p24 and gp120 antigens
were found associated with the PBMC virus pellet (Fig.
2B). Thus, no increased dissociation of p24, RT, and
gp120 was observed with virions produced by either
PBMCs or MDMs.
A shorter stationary phase of virus production than
in MDMs was observed for PBMCs lasting only 4 days
FIG. 1. Replication of HIV-1ADA in human MDMs. The infection was (Days 6 and 10, arrows). Approximately 200 ng/ml p24carried out as described under Materials and Methods. Culture medium
(Fig. 2A) or 3.8 1 109 particles of HIV-1 were madewas completely collected every 3 or 4 days after infection and subse-
quently fractionated by ultracentrifugation. The viruses were monitored within 4 days (Table 2). Quantitation of virion produc-
by determination of p24 antigens (A) reverse transcriptase (RT) activity tion by direct particle counts yielded similar values,
(B) and gp120 antigens (C). The antigen/RT activity was determined in 3.5 1 109 particles/ml, which were in close agreement
supernatant fluids before (-n-) and after (-h-) ultracentrifugation, and
with the p24 estimates (Table 2). The decline of virusin the pellets (-s-). The dot line (- - -) indicates the low limits of the
production observed in these cultures after Day 10assays. The arrow (f) indicates the time point when the culture medium
was collected and cultures were washed three times immediately after. was probably due in part to loss of cell viability
(Fig. 2D).
To contrast the growth characteristics of cell line-
Levels of RT activity and gp120 antigens in these cul- adapted HIV-1 in primary cultures with HIV-1ADA as
tures remained undetectable 5 days longer than p24 shown above, HIV-1MN/H9 was used to infect both PBMCs
concentrations following infection due to assay sensitiv- and MDMs derived from the same donor as for the HIV-
ities. 1ADA virus studies. The HIV-1MN showed a similar short
The cytopathic effects associated with active repli- log period followed by virus replication in PBMCs, as
cation were mainly the formation of multinucleated gi- measured by p24 antigens (Fig. 3A). However, unlike
ant cells. The MDM culture showed small syncytia HIV-1ADA in PBMCs, a sustained plateau phase of virus
(5 – 10 nuclei per cell) within a week after infection, replication was observed to Day 14. Overall, lower virus
which further developed into giant syncytia (50 – 100 replication (8- to 10-fold lower) and peak levels (25 ng/
nuclei per cell) after 2 to 3 weeks of infection and ml) were observed through Day 14. The majority of p24
were found to be viable for the period of experimental (97%) was also associated with pellets (Fig. 3A) and
observation (data not shown). EM and immunohisto- only a small amount (3%) was left in the supernatants
after centrifugation of the culture medium. The concentra-chemical staining revealed that extracellular virus in
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TABLE 2
Comparison of Biophysical, Biochemical, and Biological Properties of HIV-1ADA and HIV-1MN Viruses Replicated in MDMs and PBMCs
Days after infection
Virus Propertya 0 3 6 10 14 17 20 24 29
ADA made in MDM Virion concentration
(1106/ml)
p24 11.4 6.4 1.4 30b 970 3075 5870 5080 2950b
EM NDc ND ND ND ND ND 2400 3900 ND
gp120 (molecules/virion) Ld L L ND 55 190 190 90 ND
RT activity L L L L 72 73 36 41 ND
End point titers
determined in
MDM 1 2 1 4 5 4 2 3 ND
I/NI Ratio NVe 1005 NV 1003 1004 1005 1007 1006
PBMC 1 1 1 2 4 5 3 1 ND
I/NI ratio NV NV NV 1005 1005 1004 1006 1008
ADA made in PBMC Virion concentration
(1106/ml)
p24 6.3 32.0 2290 3830 731
EM ND ND ND 3490 ND
gp120 (molecules/virion) L L 50 210 50
RT activity L L 28 23 11
End-point titers
determined in
MDM 1 2 3 2 2
I/NI ratio 1005 1005 1006 1007 1007
PBMC 1 2 3 2 2
I/NI ratio 1005 1005 1006 1007 1007
MN made in PBMC Virion concentration
p24 5.9 79.0 22.0 351.0 507
EM ND ND ND ND 1950
gp120 (molecules/virion) L L L 250 190
a Virion concentration (106 virions/ml) in pellets determined by p24 and electromicroscopy (EM). gp120 concentration (gp120 molecules/virion)
calculated as the virion concentration determined by p24 concentration. RT activity (counts per minute per 106 virions determined by p24 concentra-
tion). Titers determined by detection of p24 antigens: the prespin samples were diluted in 10-fold series and titrated separately in MDMs and
PBMCs in microtiter plates, and the titers/ml are expressed as a logarithm of the highest dilutions that showed p24 positive. I/NI ratio, ratio of titers
to virion concentrations determined by p24.
b In prespin culture medium.
c Not done.
d L, below the lower limit.
e NV, No values.
tion of virus particles as determined by both p24 and EM time following a complete wash-out of cell-free virus. The
was 0.5 1 109 per milliliter and 2.0 1 109 per milliliter, average amount of the virus produced in MDMs infected
respectively (Table 2). The RT activity and gp120 concen- with HIV-1ADA between Day 20 and Day 24 was 9.2 1
trations were below detectable limits up to Day 14 and 109 virions/107 cells/day or 0.92 1 103 virions/cell/day,
Day 10, respectively (Figs. 3B and 3C). The HIV-1MN/H9 assuming that all MDMs are infected. Repeat assays dem-
strain did not productively replicate in MDMs (data not onstrated that greater than 90% of the MDM monolayer
shown). was infected as confirmed by p24 immunohistochemistry
as early as 10 days (data not shown). Virion concentrations
Estimation of virus production and rate on a per cell were derived from the average determinations measured
basis by p24 and EM and found to be 11.7 1 102 and 6.6 1 102
particles per cell, respectively (Table 2).Cell-free virus production during the stationary period
The same values at the same growth periods werewas determined on a per cell basis for both PBMCs and
determined for HIV-1ADA replicating in PBMCs betweenMDMs from the relationship between the cell concentra-
tion per T25 flask (15 1 106 total macrophages in 11 ml Day 6 and Day 10 (Figs. 2A and 2D). During the stationary
phase, the total cell number of 2.20 1 106 viable PBMCof medium) and the amount of virus produced per unit
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Estimates of virion-associated gp120, infectivity, and
infective/noninfective particle ratios
In an effort to further characterize biochemical similari-
ties or differences possibly affecting virion infectivity, tro-
pism and neutralization resulting from the replication in
primary cells, soluble and virion-associated gp120 con-
centrations, infectious titers and infective to noninfective
particle ratios (I/NI) were also determined. Virion-asso-
ciated gp120 concentrations from the same virus
supernate/pellet samples described above (infecting
MDMs) exhibited a log-linear increase in concentration
from 10 ng/ml on Day 14 to 80 and 100 ng/ml at Days
20 and 24, respectively (Fig. 1C). Concentrations of virion-
associated gp120 from HIV-1ADA infecting PBMCs were
measurable at Day 6 (20 ng/ml) and peaked at Day 10
FIG. 2. Replication of HIV-1ADA in human PBMCs and growth kinetics
of PBMCs. The viruses were monitored by the assays as shown in Fig.
1 (A, B, and C). (D) Growth kinetics of infected PBMCs (-m-) and unin-
fected controls (-j-).
cells/ml was reduced by 200,000 cells/ml to a nadir
of2.00 1 106 viable cells/ml at Day 10. Direct sampling
of cell counts and viability as well as independent HIV-
1 specific immunohistochemical studies demonstrated
that 5–10% of the cells were infected and lost during
the short stationary phase of virus production (data not
shown). The virion concentration of 3.66 1 109 particles/
ml used in the calculation was the accumulated value
collected over a 4-day interval following a complete
washout of cell-free virus at Day 6. This value was deter-
mined from the average between both the pelleted p24
value (3.83 1 109/ml) and the EM count (3.49 1 109/ml)
(Table 2). Therefore, the amount of virus produced on a
per cell basis (assuming 8% of the PBMC infected) was
approximately 5.31 1 103 virions/cell/day.
The replication of the laboratory strain HIV-1MN/H9 in FIG. 3. Replication of HIV-1MN in human PBMCs and growth kineticsPBMCs produced two- to eightfold less total virions dur- of PBMCs. The viruses were monitored by the assays as shown in Fig.
ing the relatively noncytopathic peak stationary period of 1. (A, B and C). (D) Growth kinetics of infected PBMCs (-m-), and
uninfected controls (-j-).14 days than HIV-1ADA/MDM in PBMCs (Table 2).
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(100 ng/ml) (Fig. 2C). A large portion of the total gp120 DISCUSSION
(96–100%) for HIV-1ADA measured from either MDMs or
In this study a variety of biophysical, biochemical, andPBMCs appeared to be associated with the virus pellet
biological properties including replication kinetics were(Figs. 1C and 2C). When calculated on a per virion basis,
determined for a primary, dual-tropic isolate of HIV-1 in-the gp120 concentrations ranged from 55 to 190 mole-
fecting autologous primary cultures of human MDMs andcules per virion and from 50 to 210 molecules per virion
PBMCs. Growth cycle studies performed as time coursefrom HIV-1ADA in MDMs and PBMCs, respectively (Table
with the wash-out procedure permitted for the qualitative2). Similar concentrations of virion-associated gp120
and quantitative characterization of a primary isolate ofwere observed for HIV-1 MN/H9 replicating in PBMCs and
HIV-1 during the initial lag, log-growth and stationaryranged from a high of 250 molecules per virion on Day
phases of viral replication and extends our previous stud-10 to 190 molecules on Day 14 (Table 2). In contrast, the
ies using a laboratory strain of HIV-1 (Layne et al., 1991,same HIV-1 MN/H9 virus in two separate stocks derived in
1992). To date, no such quantitative and qualitative dataH9 cells generated over a 2-year period demonstrated
of this nature have been reported for a dual-tropic pri-the typical lower virion-associated gp120 concentrations
mary isolate in reciprocal and autologous primary cellof 2.0 and 6.0 molecules per virion (data not shown).
cultures. By monitoring viral proteins p24, RT, and gp120Samples taken from HIV-1ADA during the log growth
envelope antigens in combination with direct virus parti-period in MDMs were tested for resultant infectivity on
cle counts and virus infectivity, we determined the con-both MDMs and PBMCs from the same donor. Initially,
centrations and ratios of I/NI particles in medium anda 2-log titer on MDMs (Day 3) disappeared on Day 6 and
rates of virion production on a per cell basis, as well asreached peak levels (greater than 5 logs) by Day 14.
the density and relative stability of gp120 molecules onInfectivity for MDMs declined to a level of 2 and 3 logs
a virion.per milliliter by Day 20 to Day 24, respectively (Table 2).
In both PHA-activated PBMC and differentiated MDMInfectivity of these same samples, when tested on the
cultures infected with the same m.o.i. of HIV-1ADA/MDMsame donor’s PBMCs, was negative at both Day 3 and
resulted in a significant level of newly synthesized extra-Day 6, after which 2 logs of infectivity on Day 10 and
cellular p24 after a lag phase of 0 to 3 days and 6 to 10greater than 5 logs of infectivity on Day 17 were observed
days, respectively. Following a lag phase, virus replica-(Table 2). These titers then declined from 3 logs on Day
tion increased rapidly by two to three orders of magni-20 to 1 log by Day 24 (Table 2). Serial samples from the
tude in both PBMCs and MDMs (log phase) by Day 6same time course experiments with HIV-1ADA/PBMC dem-
and Day 17, respectively. MDMs as studied in this reportonstrated a more consistent pattern of infectivity (1 to 3
demonstrated peak virus production during the stationarylogs), which was similar on both MDMs and PBMCs
phase for the entire experimental period lasting a total of(same donor). Both PBMCs and MDMs displayed the
more than 2 weeks (data not shown). The peak stationarysame infectious titers 102 (Day 3) which peaked to 103
period of viral replication for PBMCs, on the other hand,(Day 6) and declined by 1 log by Day 10 (Table 2). In
began to decline after only 4 days, apparently due in partgeneral, at least 3 logs of infectivity were present in all
to loss of cell viability. During these growth cycle studiessupernates tested before they became positive in the
both primary cell types produced similar concentrationsgp120 ELISA (4 ng/ml cutoff).
(109 particles per milliliter) during their respective peakHIV-1MN/H9 replicating in PBMCs demonstrated lower
stationary periods. On a per cell basis, an average ofand slower viral replication as evidenced in the delayed
0.92 1 103 and 5.31 1 103 virions were produced dailyappearance of virion-associated gp120 (20 ng/ml on Day
(i.e., 24 hr), respectively, by an infected MDM and a PHA-14). No soluble gp120 was measured in the postspin
activated lymphocyte in the culture flask. Interestingly,supernate demonstrating the concentration was less
despite their smaller size, PBMCs were capable of pro-than the detectable cutoff value of 4 ng/ml (Fig. 3C).
ducing 0.7 logs more virus (4400 more virions per cellThe infectious titers for HIV-1ADA/MDM and HIV-1ADA/PBMC
per day) than MDMs. This may, in part, explain a morewere determined directly and reciprocally on the same
direct cytopathic effect for the virus on CD4 lymphocytesdonor MDMs and PBMCs as described above. The I/NI
and the prolonged viability of HIV-1 infected MDMs, asratios during the growth cycle studies were then calcu-
the relative amounts of cell membrane involved in viruslated by a division of the mean infectious titer with the
production would be significantly greater for a lympho-virion concentration. The I/NI ratio of HIV-1ADA/MDM titered
cyte than a macrophage.on MDMs exhibited a dynamic range from 1:103 on Day
Previous estimates of rates and amounts of virus per10 to a value of 1:107 on Day 20, whereas, when titered
cell have been done using laboratory strains in eitheron PBMCs, a rather constant I/NI ratio was observed
PBMCs and/or T-cell lines and reported to be 102 to 104ranging from 1:105 on Day 10 to a value of 1:106 on Day
physical particles (McDougal et al., 1985; Volskey et al.,20 (Table 2). The I/NI ratio for HIV-1ADA/PBMC titered back
1990; Dimitrov et al., 1993; and Levy et al., 1996). Theon PBMCs and MDMs demonstrated a range from 1:105
on Day 3 to a value of 1:107 on Day 10 (Table 2). greater values (one log) observed in this study than pre-
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viously reported for HIV-1 in PBMCs (Levy et al., 1996) than the same donor’s PBMCs. Interestingly, virus ob-
tained just 7 days later (i.e., stationary phase) exhibit amay reflect improved in vitro differences in replication
efficiencies inherent for a given primary isolate in primary 101 decline in the I/NI ratio on MDMs, yet exhibited an
increase in the infectious fraction (101) for PBMCs. Incells and/or other variables (i.e., cell concentrations, cell
culture conditions, as well as quantitative methodologies comparision, the I/NI ratio for HIV-1ADA/PBMC replicating
in PBMCs between 0 and 10 days demonstrated loweremployed). Interestingly, whereas most of the MDMs and
human T-cell lines became infected (90%), only 5–10% infectivity as exhibited by the lower and narrower I/NI
ratio (1:105 –106) or 1 infectious particle for every 1.0 1of the PBMCs were found infected similar to a result
reported recently (Levy et al., 1996). The finding of only 105 to 1.0 1 106 particles. Similar kinetics and infectious
ratios were also shown by other primary stocks made in5–10% of the total available CD4 positive T-cells (30 –
50%) in the PBMC cultures found to be replicating the the laboratory (unpublished data) and thus the present
data may not merely be the results of a single experimentlarge amounts of virus during the peak log and stationary
phase cultures are intriguing and not readily explained. as performed in this study. The higher infectious fraction
of HIV-1ADA/MDM replicating in MDMs in vitro would beWe are currently investigating both cellular and virus
related mechanisms for this paradox. consistent with the notion of virus initially selecting mac-
rophage lineage cells located in strategic sites in vivoAs part of the quantitative studies performed in this
kinetic study, infectious titers were determined during capable of producing more infectious cell-free virus for
rapid dissemination. These findings may suggest onevirus replication in both MDMs and PBMCs. Overall, HIV-
1ADA , whether derived from autologous MDMs or PBMCs, biological explanation for macrophage tropism of lentivi-
rus and for previous reports demonstrating HIV-1 isolatedmaintained tropism and replicated in both cell types. No-
tably, during viral replication in MDMs, peak infectious from acute infections are generally monocytotropic
(Schuitemake et al., 1991; Roos et al., 1992; Zhu et al.,titers were found to occur at different times during the
long log and stationary phases of viral replication. Infec- 1993 and van’t Wout et al., 1994). In addition, some strains
are believed to more efficiently infect and replicate intivity for MDMs was observed first at Day 3 with maximal
infectivity titers observed during late log phase (Day 14) dendritic cells (Lanfhoff et al., 1991; Cameron et al., 1996)
and Langerhans’ cells derived from skin tissue (Soto-of virus replication; whereas peak infectious titers on
MDMs had fallen 1–2 logs (despite a similar average Ramirez et al., 1996) than other cell types. Similar more
quantitative autologous studies as described here willamount of virion-associated gp120 to be discussed later).
In contrast, when HIV-1ADA replicating in PBMCs was need to be done with these other cells types to confirm
this hypothesis.tested for infectivity during the same log and stationary
phases in both PBMCs and MDMs, a lower infectivity The extremely low infectious fraction when compared
to the amount of virus produced daily on a per PBMCtiter was observed and ranged between 102 and 103
throughout the 14 days of sampling, with the peak infec- basis presented an interesting paradox. More specifi-
cally, during the initial infection of both primary cell typestivity (103) occurring at Day 6 for both MDMs and PBMCs.
To further characterize the qualitative and quantitative at a m.o.i. of 0.03, approximately 5.4 1 105 cells would
have been infected. Given that the rate is only 5.3 1 103kinetics of viral replication, specifically infectivity and vi-
rus particle counts, comparisions of infectious titers and particles per cell per day at peak production, only 2.9 1
109 virions total in the culture should have been producedI/NI ratios during viral replication from primary human
lymphoid cell types were made (Table 2). The I/NI ratio in the first rounds of virus replication. At a I/NI ratio
of 1:106 –107, only 102 –103 of these in total would befor HIV-1ADA/MDM replicating in MDMs increased during
the transition from the log to the stationary phase, from infectious. Thus, another 102 or 103 PBMCs would have
been infected from the 2.9 1 109 cell-free particles. Ex-a higher (i.e., 1:103 at Day 10) to a lower (1:107 at Day
20) value demonstrating a greater infectious fraction was perimentally, however, approximately up to 2.2 1 106
cells were assumed to be infected and lost by the endproduced earlier despite the fact that more virus was
produced during the stationary, steady-state period. As of the log/stationary phases (4 days total) (Fig. 2D). Thus
the resulting productive infection of these additional 1.66much as a 4-log difference in the infectivity ratio was
noted to occur in as little as a 3- to 4-day interval (i.e., 1 106 cells (the difference between 5.4 1 105 and 2.2 1
106) is up to 3 to 4 orders of magnitude greater thanDays 10–20, Table 2). In contrast, when the same inocula
of HIV-1ADA/MDM were titered simultaneously back on the would have occurred by cell-free virus. Put in perspec-
tive, given the 2-day lag time and low cell-free infectivity,autologous donors PBMCs, a 2-log less I/NI ratio (1:105
at Day 10) was observed. This ratio increased later by infection of these additional PBMCs by 2.9 1 109 virions
would never have occurred. The apparent efficiency ofgreater than 1 log (1:104) on Day 17, and, however, re-
turned to a new maximum value (1:108) on Day 24. These HIV-1ADA/MDM infection in PBMCs, as characterized in this
study by the short lag phase and rapid, high-titered log/results demonstrate that during viral repliction from
MDMs, a greater infectious fraction (1001) exhibited in stationary phase (a total of 6 to 10 days), despite the low
I/NI ratio, strongly suggests that process(es) other thanHIV-1ADA/MDM during the log phase (Day 10) for MDMs
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cell-free transmission are operational (i.e., cell-to-cell virion over the preceding 3- to 4-day time intervals and
suggests a rather rapid qualitative and quantitativetransmission) (Gupta et al., 1989). These findings would
contribute to the neutralization resistance in PBMC, change occurs in the virus population.
It is generally accepted that the viral surface molecule(Moore and Ho, 1995) and are consistent with two earlier
reports demonstrating that cell-to-cell in vitro transmis- gp120 plays a role directly or indirectly in the initial
stages of infection of host cells (Layne et al., 1990; Wusion was 102 to 103 times greater than cell-free virus in
vitro using laboratory strains and human T-cell lines (Sato et al., 1995). Previous ultrastructural studies (for a review
see Gelderblom, 1991) showed each virion with a fullet al., 1992; Dimitrov et al., 1993). Further evidence for
this increased efficiency was reported as measured by complement of gp120 on the surface possessed approxi-
mately 70 oligomers of 3 or 4 gp120 molecules for a totalthe accumulation of full length linear viral DNA which
was found to occur within 15 min (Sato et al., 1992). of 210 to 280 molecules per virus particle. In addition, this
study and others, using laboratory strains, demonstratedLikewise we have observed single infected H9 cells ca-
pable of fusing and infecting multiple neighboring cells that spontaneous shedding of the viral-associated gp120
occurs over time resulting in progressive loss of infectiv-within 30 min (data not shown). In contrast, the infection
of MDMs appears to proceed by both cell-free and cell- ity while at the same time increasing the susceptibility
of virions to neutralization with antibody and/or sCD4to-cell spread. The former is evidenced by the lower I/
NI ratio (higher infectious fraction 1:103) which permits (Layne et al., 1991, 1992). Typical acutely harvested
stocks of HIV-1 laboratory strains generally were foundthe initially infected 4.5 1 105 cells (m.o.i. 0.03) to pro-
duce approximately 450,000 more infectious particles per to have 2–10 molecules of gp120 per virion (Layne et
al., 1992 and see Results). Interestingly, the averagedday capable of infecting another 4.5 1 105 cells per day.
The combination of a greater number of susceptible cells density of gp120 molecules per total virions for all viruses
used in this study, regardless of the primary cells usedcapable of producing a larger infectious fraction per repli-
cation cycle with a sustained capacity for viral replication to passage were about 10- to 25-fold higher than for the
same laboratory strains HIV-1MN grown in H9 cell lineallows for the infection to spread and be sustained by
cell-free viruses in vitro. These results, if extrapolated in (see Results) and HIV-1HXB3/H9 during a 48-hr period
(Layne et al., 1992). This finding suggests the concentra-vivo, may suggest that early dissemination of HIV-1, if
associated with cells of macrophage lineage, may occur tions of gp120 per virion for primary isolates and labora-
tory strains during a log/stationary phase growth cycleas cell-free viruses after which the concomitant infection
of PBMCs proceeds more efficient through cell-to-cell in primary cells result in increased amounts of gp120 in
their envelopes. This study cannot, however, rule outcontact of the relatively more mobile lymphocyte pool
(for a review see Pabst, 1988). If such a low infectivity is that virus subpopulations in the HIV-1 stocks were not
selected by the PBMCs which for whatever reason incor-operational in CD4 lymphocytes in vivo (and it appears
that it is; 105 – 107), the infection is unlikely to proceed porated more gp120. In support of our primary findings
and/or that more of the virion-associated gp120 is immu-via cell-free infectious viruses produced by CD4/ lym-
phocytes. Thus, cell-to-cell transmission would generally nologically more accessible to our polyclonal antibody
used in the ELISA, a similar result was reported for mo-be the case where the in vivo I/NI ratio was reported to
range from 1:104 to 106 (Piatak et al., 1993), but would lecular clones of a laboratory strain and primary macro-
phage-tropic isolate. Using gp120/p24 ELISA data, thenot be operational in some cases where the ratio was
1:103 or higher (Piatak et al., 1993; Perelson et al., 1996). average density of gp120 spikes on a virion of the macro-
phage-tropic viruses was significantly greater (41)Notably, the number of infectious particles produced
by a single CD4 positive lymphocyte was less than 1 per than those of T-cell-line-adapted viruses (O’Brien et al.,
1994). These studies together provide direct evidencecell per day (0.053 infectious units). This finding, when
contrasted to the 102 infectious units per cell per 3 to 4 that primary isolates of HIV-1 derived from primary
lymphoid cells appear to have greater amounts of gp120.days reported previously (Dimitrov et al., 1993) for the
laboratory strain HIV-1NL4-3 replicating in the human T- This result could again contribute significantly to the gen-
eral phenomena of neutralization resistance observedcell line A3.01 (despite the production of similar numbers
of virus particles), demonstrates the large differences with primary isolates (Layne et al., 1991, 1992; Stama-
tatos et al., 1994; for a review see Moore and Ho, 1995).which can exist in vitro depending on the virus and cell
culture systems employed. This 102 to 103 log lower infec- As spontaneous shedding of the gp120 from HIV-1
has been well characterized, samples taken during thetious fraction in PBMCs is closer to what may be ob-
served in vivo where the I/NI ratio has been reported kinetic wash-out experiments allowed for a crude charac-
terization of the spontaneous shedding rates of gp120generally to range from 1:104 to 1:106 (Piatak et al., 1993).
Paradoxically, the general declining infectious fractions from HIV-1ADA derived from MDMs and PBMCs. Interest-
ingly, HIV-1ADA/MDM replicating in MDMs during the logfor HIV-1ADA/MDM and HIV-1ADA/PBMC (low I/NI ratios) oc-
curred when the virus particle gp120 concentrations in- phase exhibited no detectable shedding of the gp120
over two sampling intervals of 96 and 72 hr durationcreased by 3 to 4 fold in the concentration of gp120 per
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effect of structure on viral function. AIDS 5, 617–638.to be prolonged when compared to the previous report
Gendelman, H. E., Orentein, J. M., Martin, M. A., Ferruca, C., Mitra, R.,
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ciency virus on recombinant colony stimulating factor 1-treatedpreliminary data in the laboratory demonstrating that
monocytes. J. Exp. Med. 167, 1428–41.other primary isolates derived from PBMCs exhibited
Gupta, P., Balachandran, R., Ho, M., Encrio, A., and Rinaldo, C. R. (1989).complete shedding of their envelopes between 10 to 72
Cell to cell transmission of human immunodeficiency virus Type I in
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